PatternsRadar
Sign in

SANOFICONRSanofi Consumer Healthcare India Limited

NSE
3,442.40INR-52.10 (-1.49%)Close · 20 Nov 2026
28 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹7,928 CrMarket cap
28.3P/E (TTM)
56.5%Delivery

Filings & corporate actions

10 results filed
CSV
Next results · Q3 FY27
Expected 28 Jan 2027 – 25 Feb 2027
Estimate: filed 28–56 days after quarter end, last 8 times
Dividend
₹75.00 per share · last 19 Jun 2026
2026
  • 28 OctresultsResults · Q2 FY27 · standalone+4.4%NSE
  • 21 OctshareholdingShareholding · 30 Sept 2026-3.1%NSE
  • 28 JulresultsResults · Q1 FY27 · standalone+0.8%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+1.1%NSE
  • 19 JundividendDividend · ₹75.00 per share-2.8%
  • 28 AprresultsResults · Q4 FY26 · standalone+2.3%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-0.8%NSE
  • 25 FebresultsResults · Q3 FY26 · standalone+13.8%NSE
  • 14 JanshareholdingShareholding · 31 Dec 2025-0.8%NSE

Reaction to results · all yearsrose on day 0 in 7 of 10 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2728 Oct 2026+4.4%+3.6%—52.0×
Q1 FY2728 Jul 2026+0.8%-3.3%-11.7%9.8×
Q4 FY2628 Apr 2026+2.3%+1.7%-2.0%7.0×
Q3 FY2625 Feb 2026+13.8%+10.0%+7.2%239.4×
Q2 FY2612 Nov 2025+7.0%+1.9%-1.2%6.7×
Q1 FY264 Aug 2025+10.4%+7.1%+8.7%39.7×
Q4 FY2512 May 20250.0%+4.4%+2.8%0.2×
Q3 FY2521 Feb 2025-0.9%+0.5%+2.0%1.9×
Q2 FY2512 Nov 2024-1.1%-2.0%-1.3%2.6×
Q1 FY2518 Sept 2024+4.0%-0.8%-6.2%—
Average+4.1%+2.3%-0.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+12.5%
Profit YoY+21.8%
Interest cost YoY-10.5%
Revenue QoQ+11.6%
Profit QoQ+11.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open3,481.10
Day range3,430.10 – 3,499.10
52-week range3,168.20 – 5,255.00
From 52w high-34.5%
RSI (14)42.3
ATR (14)118.20
Volume4.8K
Avg volume (20D)39.9K
Rel volume0.12×
Volatility (1Y)30.0%
Turnover₹1.7Cr
Traded value (NSE)₹1.7Cr
VWAP3,454.63
SMA 50 / 2003,652.90 / 4,279.99
Price band20%

Delivery percentage

Latest · 20 Nov 202656.5%
20-day avg56.1%
1-year avg55.6%
Percentile (own history)44th
Range8.7–100.0%
Sessions543

Over the last 20 sessions SANOFICONR settled 56.1% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 55.6%. The latest session ranks higher than 44% of the 543 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield2.18%
Dividend, trailing 12M₹75.00
Paid every year for1 yr
Shareholders46.6K · -1.9% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever

Performance returns

1D1W1M3M6M1Y
Price-1.49%-4.63%+5.50%-18.29%-26.58%-28.76%

Valuation

Market cap₹7,928 Cr
Market cap (NSE)₹7,928 Cr
Free-float cap₹2,278 Cr
P/E (TTM)28.3
P/E (NSE)28.8
EPS (TTM)121.45
P/B22.8
Net margin (TTM)28.6%
Other income / PBT5.6%
ROE87.9%
Debt / equity0.00
Shares outstanding2.30Cr
Listed13 Sept 2024

Ownership

Promoter71.27%
Promoter Δ QoQ0.00 pp
Public28.73%
FII2.48%
DII18.03%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)251.0229.2235.7263.1
YoY chg+47.0%+32.8%+6.7%+12.5%
Net profit (₹ Cr)66.567.868.876.6
YoY chg+50.1%+35.6%+13.3%+21.8%
Net margin26.5%29.6%29.2%29.1%
EPS28.8729.4429.8733.26

Shareholding over time

By quarter

30 Sept 2026 · promoter 71.27% · public 28.73%
6 Sept 2024: promoter 60.40%30 Sept 2024: promoter 60.40%10 Oct 2024: promoter 60.40%31 Dec 2024: promoter 60.40%31 Mar 2025: promoter 60.40%30 Jun 2025: promoter 71.27%30 Sept 2025: promoter 71.27%31 Dec 2025: promoter 71.27%31 Mar 2026: promoter 71.27%30 Jun 2026: promoter 71.27%30 Sept 2026: promoter 71.27%
2024-092026-09
  • Promoter
  • Public and others
Promoter
71.27%
Public
28.73%
Promoter change
0.00 pp
Filed
21 Oct 2026
FII
2.48%
DII
18.03%
Promoter pledged
0.00%

Who the public is

Mutual funds
12.92%

-0.09 pp QoQ

Insurance
5.11%

+0.27 pp QoQ

FPI
2.48%

-0.12 pp QoQ

Retail ≤ ₹2L
6.16%

-0.02 pp QoQ

HNI > ₹2L
0.00%

0.00 pp QoQ

NRI
0.81%

0.00 pp QoQ

Bodies corporate
0.78%

+0.01 pp QoQ

Shareholders
46,586

-1.9% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Opella Healthcare Participations B.V.Promoter · Corporate60.40%
Opal Bidco SASPromoter · Corporate10.88%
NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA GROWTH MID CAP FUNDMutual fund5.96%
ADITYA BIRLA SUN LIFE MUTUAL FUND - ADITYA BIRLA SUN LIFE CONSUMPTION FUNDMutual fund2.94%
HDFC LIFE INSURANCE COMPANY LIMITEDInsurance2.33%
ICICI PRUDENTIAL SMALLCAP FUNDMutual fund1.67%
GENERAL INSURANCE CORPORATION OF INDIAInsurance1.30%
BAJAJ LIFE INSURANCE LIMITEDInsurance1.09%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 17 Apr 2025 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹75.00₹75.00
FY2025-261₹55.00₹55.00
Ex-dateRecord dateDeclaredAdjusted
19 Jun 2026—₹75.00₹75.00
17 Apr 2025—₹55.00₹55.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
5
0 open-market of the newest 5
By year

No open-market insider trades among the recent disclosures.

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to SANOFICONR.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q1 FY25Q2 FY25Q3 FY25AQ4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations164.4159.9170.7172.6220.9233.9251.0229.2235.7263.1
Other income0.84.25.05.25.63.04.65.66.34.4
Total income165.2164.1175.7177.8226.5236.9255.6234.8242.0267.5
Total expenses102.0101.7110.0111.0154.2152.8165.1144.1150.1164.8
└ Finance costs0.13.40.40.40.50.60.50.50.40.3
└ Depreciation1.11.51.02.03.03.33.43.23.33.1
Profit before tax38.961.262.866.878.984.190.590.791.9102.7
Tax expense9.916.218.516.818.221.224.022.923.126.1
Net profit29.045.044.350.060.762.966.567.868.876.6
EPS12.5819.5419.2521.6926.3627.3128.8729.4429.8733.26
Net margin17.64%28.14%25.95%28.97%27.48%26.89%26.49%29.58%29.19%29.11%
PBT margin23.66%38.27%36.79%38.70%35.72%35.96%36.06%39.57%38.99%39.03%
Tax rate25.45%26.47%29.46%25.15%23.07%25.21%26.52%25.25%25.14%25.41%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 28 Oct 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 Q1 FY25Q3 FY25Q1 FY26Q3 FY26Q1 FY27
Total assets307.2431.3422.0547.0706.4
Current assets270.0391.7366.1494.3663.4
└ Cash & equivalents118.7326.9216.4374.8490.2
└ Other bank balances0.00.00.50.40.4
└ Current investments0.00.00.00.00.0
└ Trade receivables32.613.744.429.649.8
└ Inventories53.740.978.061.993.7
Total equity184.6273.0257.0384.0347.9
└ Attributable to owners184.6273.0257.0384.0347.9
└ Share capital23.023.023.023.023.0
Borrowings0.00.00.00.00.0
└ Current0.00.00.00.00.0
└ Non-current0.00.00.00.00.0
Trade payables28.870.393.179.6101.0
Current liabilities95.2130.6132.9128.4327.1
Total liabilities122.6158.3165.0163.0358.5
Net debt(118.7)(326.9)(216.9)(375.2)(490.6)
Debt / equity0.000.000.000.000.00
Current ratio2.843.002.753.852.03

Cash flow, year to date

 Q1 FY25Q3 FY25Q1 FY26Q3 FY26Q1 FY27
Operating cash flow231.5439.017.9277.4145.2
└ Capex(0.2)(9.9)(6.9)(7.6)(0.8)
Free cash flow231.3429.111.0269.8144.4
Investing cash flow3.21.91.4(7.6)10.5
Financing cash flow(117.6)(115.6)(129.8)(221.9)(40.3)
└ Dividends paid(115.2)0.0(126.7)(126.7)0.0
└ Buybacks(2.0)0.00.00.00.0
Net change in cash117.1325.3(110.5)47.9115.4

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SANOFICONR at a glance

  • SANOFICONR closed at ₹3,442.4 on 20 Nov 2026, -1.49% on the day, -28.8% over one year, 34.5% below its 52-week high of ₹5,255.
  • Delivery was 56.5% of traded quantity on 20 Nov 2026, the 44th percentile of its own 543 sessions with a reading (20-session average 56.1%, 1-year average 55.6%).
  • Market capitalisation is ₹7,928 crore at a trailing P/E of 28.3 (trailing EPS ₹121.45).
  • Q2 FY27 results (standalone, filed 28 Oct 2026): revenue ₹263 crore (+12.5% year on year), net profit ₹77 crore (+21.8%); the price moved +4.4% on the first session after.
  • Promoters held 71.27% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 28 Jan 2027 and 25 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE0UOS01011
SeriesEQ
Listed13 Sept 2024
NSE market cap · 17 Nov 2026₹8,135 Cr
Free-float market cap (NSE)₹2,322 Cr
Shares outstanding (NSE)2.30Cr
History from13 Sept 2024
Sessions543
Turnover rank#859

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.